🇰🇷 South Korea Country × Condition
gastric adenocarcinoma Clinical Trials in South Korea
Active clinical trials for gastric adenocarcinoma with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇰🇷 South Korea
Active Trials in South Korea (2)
NCT07607119
Recruiting
PULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric Cancer
Enrollment
53 pts
Country
🇰🇷 South Korea
Samsung Medical Center
View Trial → NCT06038578 Phase 2
Recruiting
A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
Enrollment
146 pts
Country
🇰🇷 South Korea
Toray Industries, Inc
View Trial → Frequently Asked Questions
How many gastric adenocarcinoma clinical trials are active in South Korea?
There are currently 2 active clinical trials for gastric adenocarcinoma with sites in South Korea, of which 2 are actively recruiting patients.
How can I join a gastric adenocarcinoma clinical trial in South Korea?
To join a gastric adenocarcinoma clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are gastric adenocarcinoma trials in South Korea?
Active gastric adenocarcinoma trials in South Korea span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology